No Data
No Data
No Data
No Data
No Data
Microport NeuroTech Swings to Profit in 2023 as Revenue Jumps 22%
Microport NeuroTech (HKG:2172) recorded an attributable profit of 145.5 million yuan in 2023, versus an attributable loss of 21.8 million yuan in 2022, according to the company's annual report filed w
MT NewswiresMay 1 06:42 ET
MicroPort Scientific's 2023 Loss Widens Despite Revenue Growth
MicroPort Scientific's (HKG:0853) attributable loss widened to $477.6 million, or $0.2717 per share, in 2023, from $436.5 million, or $0.2494 per share, in 2022, according to the company's annual repo
MT NewswiresMay 1 04:42 ET
2023年度報告
Futu NewsApr 29 06:39 ET · Announcements
Is There An Opportunity With MicroPort NeuroTech Limited's (HKG:2172) 43% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, MicroPort NeuroTech fair value estimate is HK$16.08 MicroPort NeuroTech's HK$9.15 share price signals that it might be 43% undervalued Ana
Simply Wall StApr 26 21:01 ET
MicroPort Scientific Insiders Forfeit On 11% Gains After Selling Stock
Despite a 11% gain in MicroPort Scientific Corporation's (HKG:853) stock price this week, shareholders shouldn't let up. The fact that insiders chose to dispose of US$2.1m worth of stock in the past
Simply Wall StApr 26 18:45 ET
Minimally Invasive Healthcare (00853): Cardiac Healthcare's net profit in the first quarter was about 184 million yuan, up 47.62% year-on-year
Minimally Invasive Healthcare (00853) announced the results of Cardiac Medical Technology for the first quarter of 2024, with revenue of about 358 million yuan, the same...
Zhitong FinanceApr 26 09:08 ET
No Data
No Data